Aurinia Pharmaceuticals (AUPH) Interest Coverage Ratio (2019 - 2026)
Aurinia Pharmaceuticals (AUPH) posted Interest Coverage Ratio of 40.93 for Q1 2026, up 368.82% on a QoQ basis from 15.23 in Q4 2025, and up 15314.78% year-over-year from N/an in Q1 2025.
Aurinia Pharmaceuticals (AUPH) Interest Coverage Ratio (2019 - 2026) Analysis & Trends
Aurinia Pharmaceuticals' Interest Coverage Ratio history runs 8 years deep, the most recent figure standing at 40.93 for Q1 2026.
- Quarterly Interest Coverage Ratio rose 15314.78% year-over-year to 40.93 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 35.93 (down 9819.57% YoY) and the FY2025 annual result came in at 1.94, up 6493.57% from the prior year.
- Interest Coverage Ratio was 40.93 for Q1 2026 at Aurinia Pharmaceuticals, up from 15.23 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 40.93 in Q1 2026 and bottomed at 248.77 in Q2 2023.
- A 5-year average of 26.65 and a median of 0.02 in 2024 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio slumped 23061.3% — and 2025, when it surged 16612.0%.
- Aurinia Pharmaceuticals' Interest Coverage Ratio stood at 31.33 in 2022, then tumbled by 421.1% to 100.59 in 2023, then jumped by 100.64% to 0.64 in 2024, then plunged by 2461.95% to 15.23 in 2025, then jumped by 368.82% to 40.93 in 2026.
- Business Quant data shows AUPH's Interest Coverage Ratio at 40.93 in Q1 2026, 15.23 in Q4 2025, and 4.14 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Aurinia Pharmaceuticals | 2.02 Bn | 1.64 Bn | 71.20 Mn | 40.93 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.93 |
| Dec 31, 2025 | -15.23 |
| Sep 30, 2025 | 4.14 |
| Jun 30, 2025 | 2.69 |
| Mar 31, 2025 | 0.27 |
| Dec 31, 2024 | 0.64 |
| Sep 30, 2024 | 8.70 |
| Jun 30, 2024 | -0.02 |
| Mar 31, 2024 | -1.49 |
| Dec 31, 2023 | -100.59 |
| Sep 30, 2023 | -9.36 |
| Jun 30, 2023 | -248.77 |
| Mar 31, 2023 | -112.49 |
| Dec 31, 2022 | 31.33 |
| Mar 31, 2022 | -0.49 |
| Dec 31, 2021 | -72.52 |
| Sep 30, 2021 | -0.60 |
| Jun 30, 2021 | -0.49 |
| Mar 31, 2021 | -4.34 |
| Dec 31, 2020 | -40.46 |